1. Home
  2. CSGS vs EVO Comparison

CSGS vs EVO Comparison

Compare CSGS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSGS
  • EVO
  • Stock Information
  • Founded
  • CSGS 1994
  • EVO 1993
  • Country
  • CSGS United States
  • EVO Germany
  • Employees
  • CSGS N/A
  • EVO N/A
  • Industry
  • CSGS EDP Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSGS Technology
  • EVO Health Care
  • Exchange
  • CSGS Nasdaq
  • EVO Nasdaq
  • Market Cap
  • CSGS 1.5B
  • EVO 1.6B
  • IPO Year
  • CSGS 1996
  • EVO 2021
  • Fundamental
  • Price
  • CSGS $64.01
  • EVO $4.44
  • Analyst Decision
  • CSGS Buy
  • EVO Buy
  • Analyst Count
  • CSGS 7
  • EVO 2
  • Target Price
  • CSGS $69.29
  • EVO $5.90
  • AVG Volume (30 Days)
  • CSGS 337.8K
  • EVO 46.1K
  • Earning Date
  • CSGS 02-05-2025
  • EVO 11-06-2024
  • Dividend Yield
  • CSGS 1.98%
  • EVO N/A
  • EPS Growth
  • CSGS 37.73
  • EVO N/A
  • EPS
  • CSGS 3.03
  • EVO N/A
  • Revenue
  • CSGS $1,197,248,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • CSGS $4.16
  • EVO $3.84
  • Revenue Next Year
  • CSGS $3.37
  • EVO $10.94
  • P/E Ratio
  • CSGS $21.31
  • EVO N/A
  • Revenue Growth
  • CSGS 2.39
  • EVO N/A
  • 52 Week Low
  • CSGS $39.56
  • EVO $2.85
  • 52 Week High
  • CSGS $65.53
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • CSGS 69.76
  • EVO 49.82
  • Support Level
  • CSGS $63.06
  • EVO $4.40
  • Resistance Level
  • CSGS $65.53
  • EVO $4.49
  • Average True Range (ATR)
  • CSGS 1.57
  • EVO 0.10
  • MACD
  • CSGS -0.02
  • EVO -0.00
  • Stochastic Oscillator
  • CSGS 80.95
  • EVO 38.46

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: